FDA clears daily pill for pancreatic cancer after 13.2-month trial survival
What's new: The drug won priority review and was cleared more than six months before the FDA's deadline.
The New York Times, BBC News (World) +2
Subject
What's new: The drug won priority review and was cleared more than six months before the FDA's deadline.